JPRN-UMIN000050678招募中Unknown
A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infections - An observational study on immunity in patients with postoperative infections
agoya University0 个研究点目标入组 75 人开始时间: 2023年3月27日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Patients within 1 months of recovery from an acute infection -Patients with chronic hepatic disorders due to HBV or HCV infections. -HIV-positive patients -Patients previously treated with chemotherapy, immune checkpoint inhibitors, or radiation therapy for malignant tumors. -Patients with active multiple cancers. -Patients with active hematologic malignancies. -Patients with hemoglobin level <= 10 g/dL. -Patients after blood stem cell transplants, including bone marrow transplants. -Patients treated for co-morbidities with high-dose glucocorticoid, immunosuppressive drugs, or biological agents. -Elderly patients who are 90 years old or older. -Pregnant women.
研究者
相似试验
招募中
不适用
A prospective observational study on host immunity for development of novel immunotherapeutic strategy in patients with severe respiratory tract infections and sepsisCommunity-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), coronavirus disease 2019 (COVID-19), and sepsisJPRN-UMIN000046739agoya University Hospital650
招募中
不适用
An observational study on host immunity in patients with refractory Mycobacterium avium complex pulmonary diseaseMycobacterium avium complex pulmonary diseaseJPRN-UMIN000043426Department of Respiratory Medicine, Nagoya University Graduate School of Medicine40
已完成
不适用
Observational study on the acquisition of immunity in convalescent people with Novel Coronavirus(COVID-19) infectioSARS-CoV-2 infectionJPRN-UMIN000044638Medical Corporation Tsurukamekai Shinjuku Tsurukame Clinic100
已完成
不适用
A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitorPatients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapyJPRN-UMIN000042962Kobe City Medical Center General Hospital Respiratory Medicine54
已完成
不适用
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52